HUM vs PGEN · P/E 39, rev $129.66B vs rev $1.8M
Humana Inc (HUM) versus Precigen Inc (PGEN) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Precigen Inc (PGEN) is a biotechnology company listed on US.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported PGEN revenue for 2023-06-30 was $1.8M. Net income was -$20.3M. Revenue was down 4.5% from 2023-03-31 to 2023-06-30. PGEN currently screens at market cap $419.2M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. PGEN currently screens at market cap $419.2M.
Not investment advice. Open the HUM and PGEN stock pages for the full models.
Not investment advice.